OBD Oxford BioDynamics Plc
0.1050GBp-8.70%Mkt Cap: 15.34M $P/E: —1d ago
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United K…
Industry Peers
Diagnostics & ResearchKey Statistics
Company
Market Cap15.34M USD
Enterprise Value7.28M USD
Revenue (TTM)1.30M USD
Gross Profit567.39K USD
Net Income (TTM)-12.12M USD
Revenue/Share0.00 GBp
Last Price0.1050 GBp
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees37
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.29
PEG—
EV/EBITDA-0.73
EV/Revenue5.61
P/S12.93
P/B1.15
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
0.08004% of range0.7500
52W High0.7500 GBp
52W Low0.0800 GBp
Profitability
Gross Margin47.67%
Oper. Margin-681.37%
EBITDA Margin0.00%
Profit Margin-1018.54%
ROE-999.37%
ROA-137.93%
Growth
Revenue Growth17.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.23M USD
CapEx (TTM)265.22K USD
FCF Margin-327.47%
FCF Yield-27.73%
Net Debt1.92M USD
Net Debt/EBITDA-0.19
Balance Sheet
Debt/Equity4.58
Current Ratio2.01
Quick Ratio1.89
Book Value/Sh0.0010 GBp
Cash/Share0.0010 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.3000 GBp
Upside (mean)+185.7%
Target Range0.3000 GBp – 0.3000 GBp
# Analysts1
Ownership
Shares Out.13.44B
Float3.27B
Insiders9.36%
Institutions33.57%
Technical
SMA 500.1186 (-11.5%)
SMA 2000.1878 (-44.1%)
Beta-0.13
S&P 52W Chg14.58%
Avg Vol (30d)30.23M
Avg Vol (10d)29.85M
Technical Indicators
RSI (14)29.4
MACD-0.0016
MACD Signal-0.0012
MACD Hist.-0.0004
BB Upper0.1220 GBp
BB Middle0.1154 GBp
BB Lower0.1088 GBp
BB Width11.38%
ATR (14)0.0132 GBp
Vol Ratio (20d)0.29x